FDA: Dough's E. coli strain differs from illness

July 10, 2009

(AP) -- The Food and Drug Administration said Thursday the strain of E. coli found in a sample of raw cookie dough collected at a Nestle USA manufacturing plant does not match the strain that has been linked to a 30-state outbreak, and they aren't sure how the dough was contaminated.

The FDA and the federal Centers for Disease Control have been investigating whether the cookie dough was the source of the E. coli outbreak which has sickened at least 69 people in about 30 states.

E. coli is a potentially deadly germ that can cause bloody diarrhea, and, in the most severe cases, .

Last month, Nestle voluntarily recalled all Toll House refrigerated cookie dough products made at its Danville, Va., factory after the FDA told Nestle it suspected consumers may have been exposed to E. coli bacteria after eating the dough raw.

On June 29, the FDA confirmed evidence of E. coli O157:H7 in a retained production sample of 16.5 oz. Nestle Toll House refrigerated chocolate chip cookie dough bar. But on Thursday, FDA spokesman Mike Herndon said tests on the dough, which came from an unopened package, show the strains of E. coli don't match the E. coli strain linked to the outbreak.

That could mean the dough may have been contaminated with multiple strains. But neither the FDA nor Nestle has discovered a probable source.

The FDA is working with the Glendale, Calif.-based unit of Switzerland-based Nestle SA on the investigation, which Herndon said was ongoing. Nestle said that during federal investigators' visit to the Danville plant, which lasted more than a week, the inspection didn't turn up a connection to E. coli.

Nestle said inspectors observed that a gate valve used on a hopper for dry ingredients required a smoother and more polished surface to allow for easier cleaning. The FDA also noted condensation dripping from a refrigeration pipe onto a large metal spatula used to scrape cookie dough from the mixer. Both of the items were corrected, the company said.

Nestle said more than 1,000 tests have been performed at the Danville facility, with the company dismantling its production lines for thorough inspection, testing equipment and ingredients, and reviewing its quality and food safety procedures.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Related Stories

Recommended for you

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Flu may be spread just by breathing, new study shows; coughing and sneezing not required

January 18, 2018
It is easier to spread the influenza virus (flu) than previously thought, according to a new University of Maryland-led study released today. People commonly believe that they can catch the flu by exposure to droplets from ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.